Neonatal screening for sickle cell disorders.
作者信息
Henthorn Joan S, Almeida Antonio M, Davies Sally C
机构信息
Faculty of Medicine, Central Middlesex Hospital Department of Haematology, Hammersmith Hospital, Imperial College London, London NW10 7NS, UK.
出版信息
Br J Haematol. 2004 Feb;124(3):259-63. doi: 10.1046/j.1365-2141.2003.04775.x.
Abstract
摘要
相似文献
1
Neonatal screening for sickle cell disorders.新生儿镰状细胞疾病筛查。
Br J Haematol. 2004 Feb;124(3):259-63. doi: 10.1046/j.1365-2141.2003.04775.x.
2
Neonatal screening for sickle cell disease: a cost-effectiveness analysis.新生儿镰状细胞病筛查：一项成本效益分析。
J Pediatr. 1991 Apr;118(4 Pt 1):546-54. doi: 10.1016/s0022-3476(05)83375-x.
3
Pitfalls in newborn hemoglobinopathy screening: failure to detect beta(+)-thalassemia.
J Pediatr. 1995 Aug;127(2):304-8. doi: 10.1016/s0022-3476(95)70316-0.
4
Biochemical neonatal screening.新生儿生化筛查
BMJ. 1990 Jun 30;300(6741):1667-8. doi: 10.1136/bmj.300.6741.1667.
5
Implementation of the newborn screening programme for sickle cell disease in England: results for 2003-2005.英格兰镰状细胞病新生儿筛查项目的实施情况：2003 - 2005年的结果
J Med Screen. 2008;15(1):9-13. doi: 10.1258/jms.2008.007063.
6
[Targeted newborn screening for sickle-cell anemia: Sickling test (Emmel test) boundaries in the prenatal assessment in West African area].[镰状细胞贫血的新生儿靶向筛查：西非地区产前评估中的镰变试验（埃默尔试验）界限]
Rev Epidemiol Sante Publique. 2018 May;66(3):181-185. doi: 10.1016/j.respe.2018.02.007. Epub 2018 Apr 4.
7
Costing model for neonatal screening and diagnosis of haemoglobinopathies.血红蛋白病新生儿筛查与诊断的成本核算模型
Arch Dis Child Fetal Neonatal Ed. 1998 Nov;79(3):F161-7. doi: 10.1136/fn.79.3.f161.
8
Sickle SCAN™ (BioMedomics) fulfills analytical conditions for neonatal screening of sickle cell disease.镰状细胞疾病扫描检测系统（BioMedomics公司）满足镰状细胞病新生儿筛查的分析条件。
Ann Biol Clin (Paris). 2018 Aug 1;76(4):416-420. doi: 10.1684/abc.2018.1354.
9
Strategy linking several analytical methods of neonatal screening for sickle cell disease.镰状细胞病新生儿筛查多种分析方法的联用策略
J Med Screen. 2001;8(1):8-14. doi: 10.1136/jms.8.1.8.
10
Screening for sickle cell disease on dried blood: a new approach evaluated on 27,000 Belgian newborns.干血片镰状细胞病筛查：在27000名比利时新生儿中评估的一种新方法。
J Med Screen. 2006;13(3):132-6. doi: 10.1258/096914106778440644.
引用本文的文献
1
Determination of birth prevalence of sickle cell disease using point of care test HemotypeSC™ at Rundu Hospital, Namibia.利用床边检测HemotypeSC™在纳米比亚伦杜医院测定镰状细胞病的出生患病率。
BMC Pediatr. 2024 May 10;24(1):323. doi: 10.1186/s12887-024-04805-z.
2
Interventions for treating leg ulcers in people with sickle cell disease.治疗镰状细胞病患者腿部溃疡的干预措施。
Cochrane Database Syst Rev. 2021 Jan 9;1(1):CD008394. doi: 10.1002/14651858.CD008394.pub4.
3
Interventions for treating leg ulcers in people with sickle cell disease.镰状细胞病患者腿部溃疡的治疗干预措施。
Cochrane Database Syst Rev. 2014 Dec 8;2014(12):CD008394. doi: 10.1002/14651858.CD008394.pub3.
4
Pilot study of hemoglobinopathies in newborns of the Rafael Calvo maternity clinic of Cartagena, Colombia.哥伦比亚卡塔赫纳拉斐尔·卡尔沃妇产诊所新生儿血红蛋白病的初步研究。
Colomb Med (Cali). 2012 Sep 30;43(3):196-9. eCollection 2012 Jul.
5
Sickle cell disease in areas of immigration of high-risk populations: a low cost and reproducible method of screening in northern Italy.高危人群移民地区的镰状细胞病：意大利北部一种低成本且可重复的筛查方法
Blood Transfus. 2014 Jul;12(3):346-51. doi: 10.2450/2013.0188-13. Epub 2014 Mar 19.
6
Neonatal screening of sickle cell anemia: a preliminary report.新生儿镰状细胞贫血筛查：初步报告。
Indian J Pediatr. 2012 Jun;79(6):747-50. doi: 10.1007/s12098-011-0682-8. Epub 2012 Jan 26.
7
HPLC studies in hemoglobinopathies.血红蛋白病的高效液相色谱研究。
Indian J Pediatr. 2007 Jul;74(7):657-62. doi: 10.1007/s12098-007-0117-8.
8
High incidence of later-onset fabry disease revealed by newborn screening.新生儿筛查显示迟发型法布里病的高发病率。
Am J Hum Genet. 2006 Jul;79(1):31-40. doi: 10.1086/504601. Epub 2006 Apr 28.
Zotero 插件